Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of L-serine, the L-enantiomer of serine, i.e. (2S)-2-amino-3-hydroxypropanoic acid. [GOC:ai, GOC:jsg]
L-serine biosynthesis is a fundamental metabolic pathway that produces the amino acid L-serine. This process is essential for various cellular functions, including protein synthesis, neurotransmitter production, and the synthesis of other essential molecules.
The L-serine biosynthetic pathway primarily involves two main routes:
1. **The Phosphoserine Pathway:**
* This is the predominant pathway in most organisms.
* It starts with the conversion of 3-phosphoglycerate, an intermediate of glycolysis, to phosphohydroxypyruvate by the enzyme 3-phosphoglycerate dehydrogenase.
* Phosphohydroxypyruvate is then reduced to phosphoserine by the enzyme phosphoserine aminotransferase, utilizing glutamate as an amino donor.
* Finally, phosphoserine phosphatase removes the phosphate group from phosphoserine, yielding L-serine.
2. **The Glycine Cleavage System (GCS) Pathway:**
* This pathway is less common and is mainly active in bacteria and some eukaryotes.
* It utilizes glycine as a substrate and involves a multi-enzyme complex, the GCS.
* The GCS catalyzes the cleavage of glycine to produce CO2, NH4+, and a one-carbon unit (N5,N10-methylenetetrahydrofolate).
* This one-carbon unit is then transferred to tetrahydrofolate, generating N5,N10-methenyltetrahydrofolate.
* Finally, this intermediate is used to convert tetrahydrofolate to 5,10-methylenetetrahydrofolate, which is required for the synthesis of serine from glycine.
The L-serine biosynthetic pathway is tightly regulated to ensure an adequate supply of L-serine while preventing its accumulation to toxic levels. Regulation occurs at multiple levels, including enzyme activity, gene expression, and feedback inhibition.
L-serine is a vital precursor for the synthesis of several essential molecules, including:
* **Glycine:** L-serine can be converted to glycine by the enzyme serine hydroxymethyltransferase.
* **Cysteine:** L-serine is a precursor for cysteine synthesis via the transsulfuration pathway.
* **Sphingolipids:** L-serine is a building block for sphingolipids, which are essential components of cell membranes.
* **Pyrimidines:** L-serine contributes to the biosynthesis of pyrimidine nucleotides, crucial components of DNA and RNA.
In summary, L-serine biosynthesis is a vital metabolic process that provides a crucial amino acid for diverse cellular functions and serves as a precursor for the synthesis of other essential molecules. The pathway is tightly regulated to ensure proper L-serine levels and maintain cellular homeostasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Serine hydroxymethyltransferase, mitochondrial | A serine hydroxymethyltransferase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P34897] | Homo sapiens (human) |
D-3-phosphoglycerate dehydrogenase | A D-3-phosphoglycerate dehydrogenase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43175] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
oxaprozin | oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis. Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE. | 1,3-oxazoles; monocarboxylic acid | analgesic; non-steroidal anti-inflammatory drug |
papaverine | papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum. Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
primaquine | primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia. Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404) | aminoquinoline; aromatic ether; N-substituted diamine | antimalarial |
flupirtine | flupirtine: RN given refers to parent cpd without isomeric designation | aminopyridine | |
duloxetine | duloxetine | ||
N-[7-(2-furanyl)-5-oxo-7,8-dihydro-6H-quinazolin-2-yl]acetamide | quinazolines | ||
pyrvinium | pyrvinium : A quinolinium ion that is 1-methylquinolinium substituted by dimethylamino group at position 6 and a (E)-2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl at position 2. It is a anthelminthic drug active against pinworms. The salts of pyrvinium can also be used as anticancer agents. pyrvinium: RN given refers to parent cpd; synonyms vanquin & vankin refer to pamoate[2:1]; structure in Merck Index, 9th ed, #7810 | quinolinium ion | anthelminthic drug; antineoplastic agent |
2-(2-furanylmethyl)-3-[[2-(3-pyridinyl)-3H-benzimidazol-5-yl]amino]-3H-isoindol-1-one | isoindoles | ||
gw2974 | GW2974: quinazoline derivative, which is able to block the activation of both the EGFR and erbB2 | pyridopyrimidine | |
N-(4,6-dimethyl-2-pyridinyl)-4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarbothioamide | piperazines; pyridines |